C12N 2502/1335
Skeletal muscle cells, myocytes, myoblasts, myotubes
C12N2502/1335 (Skeletal muscle cells, myocytes, myoblasts, myotubes) appears on 38 US grants and 72 published applications in this corpus.
Search patents in C12N- Granted patents
- 38
- Published applications
- 72
- Assignees
- 60
- Inventors
- 176
- Latest grant
- 10 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 2 |
| 2006 | 0 | 2 |
| 2007 | 0 | 4 |
| 2008 | 1 | 4 |
| 2009 | 0 | 1 |
| 2010 | 0 | 2 |
| 2011 | 1 | 4 |
| 2012 | 3 | 3 |
| 2013 | 0 | 1 |
| 2014 | 7 | 7 |
| 2015 | 3 | 3 |
| 2016 | 2 | 4 |
| 2017 | 2 | 4 |
| 2018 | 3 | 1 |
| 2019 | 2 | 4 |
| 2020 | 1 | 4 |
| 2021 | 4 | 5 |
| 2022 | 2 | 5 |
| 2023 | 2 | 2 |
| 2024 | 3 | 1 |
| 2025 | 1 | 4 |
| 2026 | 1 | 5 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Engineered intestinal tissue and uses thereof10 Feb 2026US 12,545,897 B2Organovo, Inc.
- Engineered intestinal tissue and uses thereof22 Jul 2025US 12,365,877 B2Organovo, Inc.
- Mesenchymal stem cell and use thereof for treatment of muscle injury and muscle-associated diseases26 Nov 2024US 12,150,963 B2Exostem Biotec Ltd.
- Cultured meat compositions22 Oct 2024US 12,123,025 B2Aleph Farms Ltd.
- Functional cortico-spinal-muscle assembled spheroids8 Oct 2024US 12,110,510 B2The Board of Trustees of the Leland Stanford Junior University
- Synthetic notch receptors for use in customized spatial control of multiple gene expressions and uses thereof1 Oct 2026US 2026/0297539 A1The Regents of the University of California
- Method for preparing co-differentiated cell therapeutic agent6 Aug 2026US 2026/0226416 A1The Catholic University of Korea Industry-Academic Cooperation Foundation
- Engineered intestinal tissue and uses thereof23 Jul 2026US 2026/0209711 A1Organovo, Inc.
- Hybrid cultured meat products and related methods23 Apr 2026US 2026/0107959 A1The Trustees of Boston College
- Supernatant of brown adipocytes, method for preparing same and utilization thereof22 Jan 2026US 2026/0021145 A1ID Pharma Co., Ltd.
Most cited
By later US patents
- Methods for the culture of human embryonic stem cells on human feeder cells102US 7,432,104 B2BresGen Inc. · 2008
- Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly or abnormally expressed gene19US 8,304,398 B2Academisch Ziekenhuis Leiden · 2012
- Blood brain barrier device12US 8,900,865 B2The Invention Science Fund I, LLC · 2014
- Choroid plexus device11US 8,053,220 B2The Invention Science Fund I, LLC · 2011
- Method for culturing skeletal muscle for tissue engineering8US 9,163,216 B1University of Central Florida Research Foundation, Inc. · 2015